Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate
Author(s) -
Neil S. Ryder,
Ingeborg Frank,
Marie-Claude Dupont
Publication year - 1986
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.29.5.858
Subject(s) - ergosterol , allylamine , squalene monooxygenase , biochemistry , biosynthesis , terbinafine , sterol , econazole , thiocarbamate , lanosterol , biology , pharmacology , farnesyl diphosphate farnesyltransferase , squalene , chemistry , enzyme , antifungal , itraconazole , microbiology and biotechnology , cholesterol , miconazole , prenylation , polyelectrolyte , organic chemistry , farnesyltransferase , polymer
The thiocarbamate antimycotics tolnaftate and tolciclate blocked sterol biosynthesis in fungal cells and cell extracts, with accumulation of squalene. This point of action was confirmed by the direct inhibition of microsomal squalene epoxidase from Candida albicans. There was no inhibition of other steps in ergosterol biosynthesis. In whole Candida cells, ergosterol biosynthesis inhibition was not complete at drug concentrations up to 100 mg/liter, whereas full inhibition occurred in a cell-free test system. Rat liver cell-free cholesterol biosynthesis was much less sensitive to the drugs. The biochemical action of tolnaftate and tolciclate is thus similar to that of the allylamine antimycotics naftifine and terbinafine.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom